세계의 치주질환 치료 기기 시장 예측(-2030년) : 제품별, 질환별, 치료별, 최종사용자별, 지역별

The global Periodontal disease treatment Equipment market is projected to reach USD 3.63 billion by 2030 from USD 2.58 billion in 2024, at a CAGR of 5.9% during the forecast period. This is due to increased awareness about the connection between oral health and overall systemic health, bringing the focus of both the patients and healthcare provider towards periodontal care. Increased government-driven campaigns to promote hygiene in the oral cavity and increased provision of dental insurance coverage have also added momentum towards this market. The increase in dental care infrastructures, especially in developing economies, is further fueling this market. In addition, the adoption of minimally invasive procedures and biologics as well as the discovery of new drugs has increased the efficacy of treatment, adding more fuel to the growth of the periodontal disease market players over the forecast period of 2024-2030.

"The chronic periodontitis segment of periodontal disease treatment market to hold second largest position forecast period."

Based on the disease type, the chronic periodontitis segment is anticipated to hold second largest share position during forecast period in periodontal disease treatment equipment market. This is due to increasing number of older populations are suffering from periodontal diseases. The condition will become increasingly common since chronic periodontitis is often found in older patients. Enhanced awareness regarding the relationship between oral health and systemic conditions, such as diabetes mellitus and cardiovascular disease, is generating a greater demand among patients to receive preventive and therapeutic care, which is increasing diagnoses and subsequent treatment adoption.

"The guided tissue regeneration segment is the fastest growing segment in periodontal disease treatment market."

Based on treatment type, the periodontal disease treatment market is segmented into non-surgical treatment, flap surgery, soft tissue graft, bone grafting, guided tissue regeneration and other treatments. The guided tissue regeneration segment is expected to grow at the highest CAGR due to its pivotal role in periodontal disease treatment research and development (R&D). Advances in biomaterials and tissue engineering have been made, leading to newer and more efficient and biocompatible membranes with better outcomes. GTR procedures are increasingly being adopted by dental professionals, and their growing training and availability of specialized equipment have made it highly potential. Favorable reimbursement policies in different regions coupled with an upsurge of cosmetic dentistry have also played an important role in the high growth rate of the GTR market.

"Europe accounted for the second largest share of the periodontal disease treatment market by region."

The global periodontal disease treatment equipment market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Europe is the second largest regional market for periodontal disease treatment equipment, whereas the Asia Pacific market is estimated to grow at the highest CAGR during the forecast period.

Europe holds the second-largest position in the periodontal disease treatment equipment market. The region has a well-established health infrastructure which provides better access to advanced dental care. Moreover, the significant rise in the geriatric population, which is more prone to periodontal diseases, covers the majority of the treatments required in Europe. The high awareness of oral health and preventive care services available in European countries further spur the expansion of this market. Favorable government policies, and reimbursement frameworks for dental care treatments, along with a high dental insurance coverage among the patients, supports them toward getting periodontal treatments. Ongoing research and development in dental technologies and biomaterials, including countries like Germany and Switzerland, also support this expansion in this region.

A breakdown of the primary participants referred to for this report is provided below:

• By Company Type: Tier 1-40%, Tier 2-30%, and Tier 3- 30%
• By Designation: Directors-50%, Managers-30% and Others-20%
• By Region: North America-38%, Europe-26%, Asia Pacific-15%, Latin America-11%, Middle East & Africa- 7%, GCC Countries- 3%

The major players operating in the periodontal disease treatment equipment market market are DENTSPLY SIRONA Inc. (US), Envista Holdings Corporation (US), A-dec Inc. (US), J. MORITA CORP. (Japan), Straumann Group (Switzerland), BIOLASE, Inc. (US), BEGO GmbH & Co. KG (Germany), Ultradent Products, Inc. (US), Yoshida Dental MFG. Co., Ltd. (Japan), Nakanishi Inc. (Japan), DentalEZ, Inc. (US), Geistlich Pharma AG (Switzerland), Nova Instruments (UK), NewTom (Italy), Millennium Dental Technologies, Inc. (US), PreXion, Inc. (Japan), Brasseler USA (US), AMD Lasers (US), and Bien-Air Dental (US).

Research Coverage

This report studies the periodontal disease treatment equipment market based on disease type, streatment type, end user and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five major regions (and the respective countries in these regions).

Reasons to Buy the Report

The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies for strengthening their market presence.

This report provides insights on the following pointers:

• Analysis of Key divers( Development of technologically advanced solutions, Rise in oral health disorders, Rising demand for advanced cosmetic dental procedures, Growing market for dental tourism in emerging countries restraints (High cost of dental imaging systems and lack of reimbursement for dental procedures, opportunity (Impact of DSOs on dental industry, Increasing number of dental laboratories investing in CAD/CAM technologies and Growing focus on emerging markets)
• Market Penetration: Comprehensive information on the product portfolios offered by the top players in the periodontal disease treatment market
• Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the periodontal disease treatment market
• Market Development: Comprehensive information on lucrative emerging regions
• Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the periodontal disease treatment market
• Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 MARKET SCOPE
  • 1.3.1 MARKET SEGMENTATION
  • 1.3.2 INCLUSIONS & EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
  • 1.3.4 CURRENCY CONSIDERED
• 1.4 MARKET STAKEHOLDERS

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 Key data from secondary sources
  • 2.1.2 PRIMARY DATA
    • 2.1.2.1 Key data from primary sources
    • 2.1.2.2 Key industry insights
• 2.2 MARKET SIZE ESTIMATION
• 2.3 MARKET BREAKDOWN & DATA TRIANGULATION
• 2.4 MARKET SHARE ASSUMPTIONS
• 2.5 RISK ASSESSMENT
• 2.6 RESEARCH LIMITATIONS
  • 2.6.1 METHODOLOGY-RELATED LIMITATIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 PERIODONTAL DISEASE TREATMENT MARKET OVERVIEW
• 4.2 ASIA PACIFIC: PERIODONTAL DISEASE TREATMENT MARKET, BY END USER & COUNTRY (2023)
• 4.3 PERIODONTAL DISEASE TREATMENT MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
• 4.4 REGIONAL MIX: PERIODONTAL DISEASE TREATMENT MARKET (2024-2030)

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Increasing prevalence of oral disorders
    • 5.2.1.2 Rising cases of edentulism
    • 5.2.1.3 Emergence of innovative dental treatment procedures
    • 5.2.1.4 Expanding market for dental tourism in emerging economies
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 High cost of advanced treatments and inadequate reimbursements for dental procedures
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Impact of DSOs on dental industry
    • 5.2.3.2 Growing awareness about oral health
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Shortage of skilled dental practitioners
• 5.3 INDUSTRY TRENDS
  • 5.3.1 INCREASING PREFERENCE OF MINIMALLY INVASIVE DENTAL PROCEDURES
  • 5.3.2 MARKET CONSOLIDATION
  • 5.3.3 DENTAL INSURANCE IN US
• 5.4 TECHNOLOGY ANALYSIS
  • 5.4.1 KEY TECHNOLOGIES
    • 5.4.1.1 3D printers
    • 5.4.1.2 Artificial intelligence
  • 5.4.2 ADJACENT TECHNOLOGIES
    • 5.4.2.1 Virtual reality
    • 5.4.2.2 Laser dentistry
• 5.5 VALUE CHAIN ANALYSIS
• 5.6 ECOSYSTEM MAP
• 5.7 SUPPLY CHAIN ANALYSIS
• 5.8 REGULATORY ANALYSIS
  • 5.8.1 REGULATORY LANDSCAPE
    • 5.8.1.1 US
    • 5.8.1.2 EU
    • 5.8.1.3 China
  • 5.8.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• 5.9 PATENT ANALYSIS
  • 5.9.1 PATENT PUBLICATION TRENDS FOR PERIODONTAL DISEASE TREATMENT
  • 5.9.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
• 5.10 TRADE ANALYSIS
• 5.11 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
• 5.12 ADJACENT MARKETS FOR PERIODONTAL DISEASE TREATMENT
• 5.13 CASE STUDY ANALYSIS
  • 5.13.1 CASE STUDY 1: INNOVATION TRACKING, TECHNOLOGY ASSESSMENT, AND PRODUCT LAUNCHES IN ANTIMICROBIAL AGENTS & COATING SUBSTANCES FOR DENTAL IMPLANTS
  • 5.13.2 CASE STUDY 2: CUSTOMIZED STUDY FOR MEA
  • 5.13.3 CASE STUDY 3: CUSTOMIZED STUDY FOR LATIN AMERICA
• 5.14 PORTER'S FIVE FORCES ANALYSIS
  • 5.14.1 THREAT OF NEW ENTRANTS
  • 5.14.2 THREAT OF SUBSTITUTES
  • 5.14.3 BARGAINING POWER OF SUPPLIERS
  • 5.14.4 BARGAINING POWER OF BUYERS
  • 5.14.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.15 KEY CONFERENCES & EVENTS, 2024
• 5.16 PRICING ANALYSIS
  • 5.16.1 AVERAGE COST OF PERIODONTAL DISEASE TREATMENT SYSTEMS (2021-2023) (USD)
  • 5.16.2 AVERAGE COST RANGE OF PERIODONTAL DISEASE TREATMENT, BY REGION (2021-2023) (USD)
  • 5.16.3 AVERAGE SELLING PRICE OF PERIODONTAL DISEASE TREATMENT, BY PRODUCT TYPE
• 5.17 KEY STAKEHOLDERS AND BUYING CRITERIA
  • 5.17.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.17.2 BUYING CRITERIA
• 5.18 UNMET NEEDS IN PERIODONTAL DISEASE TREATMENT MARKET
• 5.19 INVESTMENT & FUNDING SCENARIO
• 5.20 PREVALENCE OF GINGIVAL CASES IN KEY COUNTRIES
• 5.21 ANALYSIS OF TOTAL NUMBER OF SURGERIES IN KEY COUNTRIES

6 PERIODONTAL DISEASE TREATMENT MARKET, BY PRODUCT

• 6.1 INTRODUCTION
• 6.2 EQUIPMENT
  • 6.2.1 GROWING PREFERENCE FOR MIS PROCEDURES TO DRIVE MARKET
• 6.3 CONSUMABLES
  • 6.3.1 RECURRING NATURE & FREQUENT PURCHASE TO PROPEL MARKET
• 6.4 MEDICATION
  • 6.4.1 GROWING AWARENESS OF ORAL HEALTH AND IMPROVEMENTS IN ANTIBIOTICS TO SUPPORT MARKET

7 PERIODONTAL DISEASE TREATMENT MARKET, BY DISEASE

• 7.1 INTRODUCTION
• 7.2 GINGIVITIS
  • 7.2.1 ACUTE GINGIVITIS
    • 7.2.1.1 Prevalence in children and adolescents to drive market
  • 7.2.2 RECURRENT GINGIVITIS
    • 7.2.2.1 Recurrent cases of bacterial infection due to poor oral hygiene to fuel market
  • 7.2.3 CHRONIC GINGIVITIS
    • 7.2.3.1 Prolonged inflammation of gums to support market growth
• 7.3 CHRONIC PERIODONTITIS
  • 7.3.1 INCREASING CASES OF EDENTULISM TO FUEL MARKET
• 7.4 AGGRESSIVE PERIODONTITIS
  • 7.4.1 RAPID TOOTH LOSS AND UNDERLYING HEALTH CONDITIONS TO CONTRIBUTE TO MARKET GROWTH
• 7.5 OTHER DISEASES

8 PERIODONTAL DISEASE TREATMENT MARKET, BY TREATMENT

• 8.1 INTRODUCTION
• 8.2 NON-SURGICAL TREATMENT
  • 8.2.1 SCALING
    • 8.2.1.1 Ability to inhibit bacterial infection to fuel uptake
  • 8.2.2 ROOT PLANING
    • 8.2.2.1 Reduction of gingival pockets to support market growth
  • 8.2.3 MEDICATION THERAPY
    • 8.2.3.1 Topical therapy
      • 8.2.3.1.1 Uptake of antimicrobial gels and mouth rinses to drive market
    • 8.2.3.2 Systemic therapy
      • 8.2.3.2.1 Utilization of host-modulating agents and antibiotics to drive market
• 8.3 FLAP SURGERY/POCKET REDUCTION THERAPY
  • 8.3.1 COMMON SURGICAL PROCEDURE FOR ADVANCED PERIODONTAL DISEASES TO DRIVE MARKET
• 8.4 SOFT TISSUE GRAFT
  • 8.4.1 PREVALENCE OF GINGIVAL RECESSION TO FUEL UPTAKE
• 8.5 BONE GRAFTING
  • 8.5.1 GROWING FOCUS ON REGENERATION OF BONES TO FUEL UPTAKE
• 8.6 GUIDED TISSUE REGENERATION
  • 8.6.1 HIGH SUCCESS RATE TO PROPEL MARKET
• 8.7 OTHER TREATMENTS

9 PERIODONTAL DISEASE TREATMENT MARKET, BY END USER

• 9.1 INTRODUCTION
• 9.2 HOSPITALS
  • 9.2.1 AVAILABILITY OF ADVANCED EQUIPMENT FOR DENTISTRY AND GROWING FOCUS ON DENTAL TOURISM TO PROPEL MARKET
• 9.3 PRIVATE & DSO CLINICS
  • 9.3.1 INCREASING ESTABLISHMENT OF PRIVATE PRACTICES TO DRIVE MARKET
• 9.4 ACADEMIC & RESEARCH INSTITUTES
  • 9.4.1 R&D FUNDING INITIATIVES TO SUPPORT MARKET GROWTH

10 PERIODONTAL DISEASE TREATMENT MARKET, BY REGION

• 10.1 INTRODUCTION
• 10.2 NORTH AMERICA
  • 10.2.1 NORTH AMERICA: MACROECONOMIC OUTLOOK
  • 10.2.2 US
    • 10.2.2.1 Favorable reimbursement policies for dental procedures to drive market
  • 10.2.3 CANADA
    • 10.2.3.1 Rising incidence of dental caries to drive market
• 10.3 EUROPE
  • 10.3.1 EUROPE: MACROECONOMIC OUTLOOK
  • 10.3.2 GERMANY
    • 10.3.2.1 Hub for advanced dentistry technologies to propel market
  • 10.3.3 FRANCE
    • 10.3.3.1 Favorable government healthcare policies to fuel uptake
  • 10.3.4 UK
    • 10.3.4.1 Increasing incidence of dental disorders to drive market
  • 10.3.5 ITALY
    • 10.3.5.1 Low-cost dental treatments to support market growth
  • 10.3.6 SPAIN
    • 10.3.6.1 Privatization of dental clinics and uptake of advanced technologies to support market growth
  • 10.3.7 REST OF EUROPE
• 10.4 ASIA PACIFIC
  • 10.4.1 ASIA PACIFIC: MACROECONOMIC OUTLOOK
  • 10.4.2 CHINA
    • 10.4.2.1 Growing prevalence of dental diseases to drive market growth in China
  • 10.4.3 JAPAN
    • 10.4.3.1 Rising geriatric population and favorable reimbursement scenario to support market growth
  • 10.4.4 INDIA
    • 10.4.4.1 Expansion of dentistry and growing awareness of oral hygiene to drive market
  • 10.4.5 AUSTRALIA
    • 10.4.5.1 Favorable government initiatives and growing prevalence of dental diseases to drive market
  • 10.4.6 SOUTH KOREA
    • 10.4.6.1 Increasing cases of edentulism to fuel uptake
  • 10.4.7 REST OF ASIA PACIFIC
• 10.5 LATIN AMERICA
  • 10.5.1 LATIN AMERICA: MACROECONOMIC OUTLOOK
  • 10.5.2 MEXICO
    • 10.5.2.1 Growth in dental tourism to drive market
  • 10.5.3 BRAZIL
    • 10.5.3.1 Trend of cosmetic dentistry to propel market
  • 10.5.4 ARGENTINA
    • 10.5.4.1 increasing use of CAD/CAM systems to support market growth
  • 10.5.5 REST OF LATIN AMERICA
• 10.6 MIDDLE EAST & AFRICA
  • 10.6.1 RISING AWARENESS ABOUT DENTAL HYGIENE TO SUPPORT MARKET GROWTH
  • 10.6.2 MIDDLE EAST & AFRICA: MACROECONOMIC OUTLOOK
• 10.7 GCC COUNTRIES
  • 10.7.1 GROWING DEMAND FOR PERSONALIZED DENTISTRY TO DRIVE MARKET
  • 10.7.2 GCC COUNTRIES: MACROECONOMIC OUTLOOK

11 COMPETITIVE LANDSCAPE

• 11.1 INTRODUCTION
• 11.2 KEY PLAYER STRATEGY/RIGHT TO WIN
  • 11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN PERIODONTAL DISEASE TREATMENT MARKET
• 11.3 REVENUE ANALYSIS, 2019-2023
• 11.4 MARKET SHARE ANALYSIS, 2023
• 11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
  • 11.5.1 STARS
  • 11.5.2 EMERGING LEADERS
  • 11.5.3 PERVASIVE PLAYERS
  • 11.5.4 PARTICIPANTS
  • 11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
    • 11.5.5.1 Company footprint
    • 11.5.5.2 Region footprint
    • 11.5.5.3 Product footprint
    • 11.5.5.4 Disease footprint
    • 11.5.5.5 Treatment footprint
    • 11.5.5.6 End-user footprint
• 11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
  • 11.6.1 PROGRESSIVE COMPANIES
  • 11.6.2 RESPONSIVE COMPANIES
  • 11.6.3 DYNAMIC COMPANIES
  • 11.6.4 STARTING BLOCKS
  • 11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
• 11.7 COMPANY VALUATION & FINANCIAL METRICS
  • 11.7.1 FINANCIAL METRICS
  • 11.7.2 COMPANY VALUATION
• 11.8 BRAND/PRODUCT COMPARISON
• 11.9 R&D EXPENDITURE
• 11.10 COMPETITIVE SCENARIO
  • 11.10.1 PRODUCT LAUNCHES & APPROVALS
  • 11.10.2 DEALS
  • 11.10.3 EXPANSIONS

12 COMPANY PROFILES

• 12.1 KEY PLAYERS
  • 12.1.1 DENTSPLY SIRONA
    • 12.1.1.1 Business overview
    • 12.1.1.2 Products offered
    • 12.1.1.3 Recent developments
      • 12.1.1.3.1 Product launches
      • 12.1.1.3.2 Deals
    • 12.1.1.4 MnM view
      • 12.1.1.4.1 Key strengths
      • 12.1.1.4.2 Strategic choices
      • 12.1.1.4.3 Weaknesses & competitive threats
  • 12.1.2 ENVISTA HOLDINGS CORPORATION
    • 12.1.2.1 Business overview
    • 12.1.2.2 Products offered
    • 12.1.2.3 Recent developments
      • 12.1.2.3.2 Product approvals
      • 12.1.2.3.3 Deals
    • 12.1.2.4 MnM view
      • 12.1.2.4.1 Key strengths
      • 12.1.2.4.2 Strategic choices
      • 12.1.2.4.3 Weaknesses & competitive threats
  • 12.1.3 INSTITUT STRAUMANN AG
    • 12.1.3.1 Business overview
    • 12.1.3.2 Products offered
    • 12.1.3.3 Recent developments
      • 12.1.3.3.1 Product launches
      • 12.1.3.3.2 Deals
      • 12.1.3.3.3 Expansions
    • 12.1.3.4 MnM view
      • 12.1.3.4.1 Key strengths
      • 12.1.3.4.2 Strategic choices
      • 12.1.3.4.3 Weaknesses & competitive threats
  • 12.1.4 HENRY SCHEIN, INC.
    • 12.1.4.1 Business overview
    • 12.1.4.2 Products offered
    • 12.1.4.3 Recent developments
      • 12.1.4.3.1 Deals
    • 12.1.4.4 MnM view
      • 12.1.4.4.1 Key strengths
      • 12.1.4.4.2 Strategic choices
      • 12.1.4.4.3 Weaknesses & competitive threats
  • 12.1.5 BIOLASE, INC.
    • 12.1.5.1 Business overview
    • 12.1.5.2 Products offered
    • 12.1.5.3 Recent developments
      • 12.1.5.3.1 Product launches
  • 12.1.6 GEISTLICH PHARMA AG
    • 12.1.6.1 Business overview
    • 12.1.6.2 Products offered
  • 12.1.7 J. MORITA CORP.
    • 12.1.7.1 Business overview
    • 12.1.7.2 Products offered
    • 12.1.7.3 Recent developments
      • 12.1.7.3.1 Product launches
      • 12.1.7.3.2 Deals
  • 12.1.8 NAKANISHI INC.
    • 12.1.8.1 Business overview
    • 12.1.8.2 Products offered
  • 12.1.9 A-DEC INC.
    • 12.1.9.1 Business overview
    • 12.1.9.2 Products offered
  • 12.1.10 RTI SURGICAL
    • 12.1.10.1 Business overview
    • 12.1.10.2 Products offered
    • 12.1.10.3 Recent developments
      • 12.1.10.3.1 Deals
  • 12.1.11 YOSHIDA DENTAL MFG.CO. LTD.
    • 12.1.11.1 Business overview
    • 12.1.11.2 Products offered
  • 12.1.12 KEYSTONE DENTAL INC.
    • 12.1.12.1 Business overview
    • 12.1.12.2 Products offered
    • 12.1.12.3 Recent developments
      • 12.1.12.3.1 Deals
  • 12.1.13 ULTRADENT PRODUCTS, INC.
    • 12.1.13.1 Business overview
    • 12.1.13.2 Products offered
  • 12.1.14 BEGO GMBH & CO. KG
    • 12.1.14.1 Business overview
    • 12.1.14.2 Products offered
    • 12.1.14.3 Recent developments
      • 12.1.14.3.1 Deals
  • 12.1.15 DENTALEZ INC.
    • 12.1.15.1 Business overview
    • 12.1.15.2 Products offered
    • 12.1.15.3 Recent developments
      • 12.1.15.3.1 Product launches
  • 12.1.16 PARKELL, INC.
    • 12.1.16.1 Business overview
    • 12.1.16.2 Products offered
    • 12.1.16.3 Recent developments
      • 12.1.16.3.1 Product launches
• 12.2 OTHER PLAYERS
  • 12.2.1 MILLENNIUM DENTAL TECHNOLOGIES INC.
  • 12.2.2 BRASSELER USA
  • 12.2.3 AMD LASERS
  • 12.2.4 NOVA INSTRUMENTS
  • 12.2.5 BOTISS BIOMATERIALS GMBH
  • 12.2.6 CONVERGENT DENTAL
  • 12.2.7 NOVABONE
  • 12.2.8 REGENITY
  • 12.2.9 HANNOX INTERNATIONAL CORP.

13 APPENDIX

• 13.1 DISCUSSION GUIDE
• 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 13.3 CUSTOMIZATION OPTIONS
• 13.4 RELATED REPORTS
• 13.5 AUTHOR DETAILS